Japan Recombinant Proteins Market Size & Outlook

The recombinant proteins market in Japan is expected to reach a projected revenue of US$ 309.0 million by 2030. A compound annual growth rate of 11% is expected of Japan recombinant proteins market from 2025 to 2030.
Revenue, 2024 (US$M)
$159.7
Forecast, 2030 (US$M)
$309.0
CAGR, 2025 - 2030
11%
Report Coverage
Japan

Japan recombinant proteins market highlights

  • The Japan recombinant proteins market generated a revenue of USD 159.7 million in 2024 and is expected to reach USD 309.0 million by 2030.
  • The Japan market is expected to grow at a CAGR of 11.6% from 2025 to 2030.
  • In terms of segment, cytokines & growth factors was the largest revenue generating product in 2024.
  • Cytokines & Growth Factors is the most lucrative product segment registering the fastest growth during the forecast period.

Recombinant proteins market data book summary

Market revenue in 2024USD 159.7 million
Market revenue in 2030USD 309.0 million
Growth rate11.6% (CAGR from 2024 to 2030)
Largest segmentCytokines & growth factors
Fastest growing segmentCytokines & Growth Factors
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCytokines & Growth Factors, Antibodies, Immune checkpoint proteins, Virus Antigens, Enzymes, Recombinant Regulatory Protein, Hormones
Key market players worldwideAbcam PLC, Sino Biological, Bio-Techne Corp, Genscript Biotech Corp Class H, Bio-Rad Laboratories Inc, Merck KGaA, Thermo Fisher Scientific Inc, Proteintech Group, Enzo Biochem Inc, Abnova, RayBiotech, STEMCELL Technologies

Other key industry trends

  • In terms of revenue, Japan accounted for 5.3% of the global recombinant proteins market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China recombinant proteins market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 319.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Recombinant Proteins Market Companies

Name Profile # Employees HQ Website

Japan recombinant proteins market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to recombinant proteins market will help companies and investors design strategic landscapes.


Cytokines & growth factors was the largest segment with a revenue share of 26.24% in 2024. Horizon Databook has segmented the Japan recombinant proteins market based on cytokines & growth factors, antibodies, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory protein, hormones covering the revenue growth of each sub-segment from 2018 to 2030.


  • Japan Recombinant Proteins Product Outlook (Revenue, USD Million, 2018-2030)
    • Cytokines & Growth Factors
      • Interferons (IFNs)
      • Interleukins (ILs)
      • Others
    • Antibodies
    • Immune checkpoint proteins
    • Virus Antigens
    • Enzymes
      • Kinases
      • Metabolic enzymes
      • Others
    • Recombinant Regulatory Protein
    • Hormones
    • Others
  • Japan Recombinant Proteins Application Outlook (Revenue, USD Million, 2018-2030)
    • Drug Discovery & Development
    • Research
    • Others
    • Therapeutics
      • Biologics
      • Vaccines
      • Cell & Gene Therapies
      • Others
  • Japan Recombinant Proteins Host Cells Outlook (Revenue, USD Million, 2018-2030)
    • Mammalian Systems
    • Insect Cells
    • Yeast & Fungi
    • Bacterial Cells
    • Others
  • Japan Recombinant Proteins End Use Outlook (Revenue, USD Million, 2018-2030)
    • Pharmaceutical & Biotechnology Companies
    • Academic & Research Institutes
    • Diagnostic Laboratories
    • Others

Reasons to subscribe to Japan recombinant proteins market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Japan recombinant proteins market databook

  • Our clientele includes a mix of recombinant proteins market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Japan recombinant proteins market , including forecasts for subscribers. This country databook contains high-level insights into Japan recombinant proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Japan recombinant proteins market size, by product, 2018-2030 (US$M)

Japan Recombinant Proteins Market Outlook Share, 2024 & 2030 (US$M)

Japan recombinant proteins market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more